source
- China gene editing startup YolTech raises $70M to move CRISPR therapies forwardOne of China’s most prolific gene editing companies has raised its biggest round of funding yet, ahead of plans to go public in Hong Kong. While most gene editing companies in the US trimmed their ...Endpoints · 2mo ago↗ source
- Oura pushes deeper into healthcare services as part of new ring launchAlongside the debut of Oura's smaller Ring 5, the wearables company on Thursday unveiled its plans to help users integrate health records and translate their ring’s findings into medical care. Oura…Endpoints · 2mo ago↗ source
- AbbVie clinches FDA approval for ultra-rare blood cancer ADC from ImmunoGen purchaseAbbVie said the FDA has approved an antibody-drug conjugate it obtained as part of its $10.1 billion buyout of ImmunoGen for an ultra-rare but aggressive form of blood cancer. On Wednesday, the ...